Stockreport

Earnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79 [Yahoo! Finance]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF Revenues of US$19m came in a modest 8.1% below forecasts. Statutory losses were a relative bright spot though, with a per-share loss of US$0.22 coming in a substantial 3 [Read more]